IP Library Granted Patent US 7,115,407
Granted Patent B2
US 7,115,407 · App. 10/616,624 · Granted Oct 3, 2006

Recombinant type II restriction endonucleases, MmeI and related endonucleases and methods for producing the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,115,407
App. No.
10/616,624
Granted
Oct 3, 2006
Kind
B2
Abstract

In accordance with the present invention, there is provided a DNA (deoxyribonucleic acid) fragment which encodes the MmeI type II restriction endonuclease enzyme. This one polypeptide possesses two related enzymatic functions; namely an endonuclease activity which recognizes the DNA sequence 5′-TCC(Pu)AC-3′ and cleaves as indicated by the arrows: 5′-TCCRAC(N20)↓-3′ 3′-AGGYTG(N18)↑-5′ and a second enzymatic activity that recognizes the same DNA sequence, 5′-TCC(Pu)AC-3′, but modifies this sequence by the addition of a methyl group to prevent cleavage by the MmeI endonuclease activity.

Claims (6)

1. Isolated DNA coding for the MmeI restriction enzyme, wherein the isolated DNA is obtainable from Methylophilus methylotrophus.

2. A recombinant DNA vector comprising a vector into which a DNA segment coding for the MmeI restriction enzyme has been inserted.

3. Isolated DNA coding for the MmeI endonuclease and methyltransferase, wherein the isolated DNA is obtainable from ATCC Accession No. PTA-4521.

4. A cloning vector that comprises the isolated DNA of claim 3 .

5. A host cell transformed by the vector of claim 2 or 4 .

6. A method of producing recombinant MmeI restriction endonuclease and MmeI methylase comprising culturing a host cell transformed with the vector of claims 2 or 4 under conditions suitable for expression of said endonuclease and methylase.

Assignments (1)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Sep 20, 2023
From: BANK OF AMERICA, N.A. (AS SUCCESSOR-BY-MERGER WITH FLEET NATIONAL BANK)
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 064962/0066 →